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Effects	of	type	1	interferon	deficiency	on	B-cells	in	lupus-prone	
mice
Introduc)on	
IFNAR	flx/flx	mice	exhibit	lower	spleen	
weight	and	splenocyte	count	than	IFNAR	+/
+	and	flx/+	mice	
Materials	and	Methods	
IFNAR	flx/flx	mice	exhibit	a	lower	
concentraEon	of	serum	anE-chromaEn	IgG	
anEbodies	than	control	mice	
Conclusions	
IFNAR	flx/flx	mice	show	similar	deposiEon	of	
IgG	than	IFNAR	+/+	and	flx/+	mice	
•  Systemic	Lupus	Erythematosus	(SLE)	is	a	
debilitaEng	autoimmune	disease	that	
affects	over	5	million	people	worldwide	
•  Lupus	occurs	more	frequently	in	females	
than	in	males	(8:1)	
•  Disease	determining	factors	include	
geneEcs,	environmental	factors	and	sex	
hormones	
•  Symptoms	of	SLE	in	paEents	vary	and	
can	have	mulEple	affects	including	
anemia,	hair	loss	and	glomerulonephriEs	
•  Deficiency	in	IFNAR	ameliorates	disease	
(Jorgensen	et	al,	2007)	and	elevaEng	
endogenous	type	I	interferons,	
accelerates	disease	development	
(Jorgensen	et	al,	2006).	
	
•  Type	1	interferon	is	produced	from	
plasmacytoid	dendriEc	cells	through	
TLR7	and	TLR9	acEvaEon	and	signals	
through	IFNAR	
•  IFNAR	acEvaEon	in	B	cells	leads	to	
autoanEbody	producEon	in	SLE	paEents	
•  B6.Nba2	backcrossed	mice	develop	a	
lupus-like	disease	
Results	
B-cell	specific	IFNAR	deficiency	in	B6.Nba2	
lupus-prone	mice	results	in:	
•  Significantly	lower	spleen	weight	
•  Significantly	lower	splenocyte	count	
•  Significantly	lower	anE-chromaEn	IgG	
levels	
•  But,	no	difference	in	immune	complex	
deposiEon	and	C3	fixaEon.	
References	
Hypothesis	
Specific	dele)on	of	IFNAR	in	B	cells	will	
decrease	autoan)body	produc)on,	
immune	complex	forma)on	and	
deposi)on	
IFNAR	flx/flx	mice	show	similar	deposiEon	of	
IgM/C3	than	IFNAR	+/+		and	flx/+	mice	
•  Cre	recombinase	is	a	reliable	method	
used	in	IFNAR	gene	knockout	that	
recognizes	and	splices	specific	DNA	
sequences	(LoxP	sites)	
	
•  Genotyping	by	ear	clipping:	DigesEon,	
DNA	extracEon,	PCR,	Gel-
electrophoresis	
•  Flow	Cytometry	was	used	for	the	
idenEficaEon	of	cell	subsets/
subpopulaEons		
•  Enzyme-linked	immunosorbent	assay	
(ELISA)	was	used	to	measure	total	IgG,	
IgM,	and	anE-chromaEn	IgG	
concentraEons.	
•  Immunofluorescence	staining	of	kidney	
samples	with	IgG-TxRd	(1:500)	and	C3-
FITC	(1:500)	
•  Project	sample	size	of	B6.Nba2	mice:	 
Figure 1: Plasmacytoid dendritic cell and associated lupus pathways (1) 
Figure 2: Cre recombinase methods of use (2) 
Figure 3: IFNAR flx/flx kidney 
samples taken at 9 months 
Figure 4: IFNAR +/+ kidney 
samples taken at 9 months 
Figure 5: IFNAR flx/flx kidney 
samples taken at 9 months 
Figure 6: IFNAR f+/+ kidney 
samples taken at 9 months 
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